Privately-held German drugmaker Grünenthal has acquired commercial rights to erectile dysfunction drug Cialis (tadalafil) in Mexico, Brazil and Colombia from US pharma major Eli Lilly.

Swiss biotech iOnctura has appointed Steven Sciuto as chief financial officer and Michelle Tsai as chief operating officer, ...

Research news last week included Rocket Pharmaceuticals suffering a setback with its Phase II trial of RP-A501, which ...

The US Food and Drug Administration (FDA) has approved mNEXSPIKE (mRNA-1283), a new vaccine against COVID-19, US mRNA ...

Canadian clinical-stage biotech Zymeworks (Nasdaq: ZYME) today announced that the National Medical Products Administration ...

UK health technology assessor the National Institute for Health and Care Excellence (NICE) has published updated Final Draft Guidance recommending Forxiga (dapagliflozin) as an option to treat chronic ...

Japanese drugmaker Sumitomo Pharma (TYO: 4506) and Denmark’s Novo Nordisk (NOV: N) have entered into a co-promotion agreement ...

Japanese drugmaker Astellas Pharma (TYO: 4503) today announced an exclusive license agreement with China’s Evopoint ...

A typical advertisement for a prescription drug airs on television. The visuals are lively and upbeat; the people are smiling ...

Industry stakeholders have urged the European Medicines Agency to sharpen its guidance on decentralized clinical trials, ...

Philadelphia-based biotech Vivodyne has raised $40 million in series A funding to advance its fully robotic, AI-powered ...

Swiss pharma giant Roche (ROG: SIX) today announced new, 96-week data for fenebrutinib demonstrating that patients with ...